NCT00042432 - Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

March 31, 2003

Study Completion Date

August 31, 2003

Conditions

Secondary HyperparathyroidismChronic Renal Insufficiency

Interventions

DRUG

cinacalcet (AMG 073)

Initially receive 1 tablet of study medication (cinacalcet or placebo) once daily. Possible sequential dose titrations are 30, 60, 90, 120, 180mg cinacalcet or placebo) daily. The titration phase was 12 weeks and the efficacy assessment phase was 6 weeks.